Plain English with Derek Thompson15 Dec 2023

How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

Today’s episode is our second in a series on the weight-loss drug revolution of the last two years. On Tuesday, we talked to endocrinologist Beverly Tchang about the science of glucagon like peptide 1 receptor agonists—also known as GLP1s, also known as Ozempic, Wegovy, Moujargo, and Zepbound. If you haven’t listened to that show, I think you’ll feel safe and entertained within the bounds of this episode. But if you want to know more about how these drugs work, their effect on insulin and glucose and the brain’s reward center, or the questions they raise about obesity and the nature of willpower and free will, I’d encourage you to queue up that show. Today, in Part 2, we have two guests: Zach Reitano is the CEO and cofounder of the telehealth platform Ro. He is here for a couple reasons. He has a bird’s-eye view of the GLP1 marketplace, the rise in demand, the supply chain, the economics of pricing and insurance. He’s also written several revelatory essays, pulling in research from think tanks, medical experts, and investment banks, that have helped shape my understanding of these drugs and the effect they could have on the population and the economy. Our second guest is Dr. Robert Lustig, an endocrinologist who spent years as a pediatrician and researcher at the University of California-San Francisco. As you’ll hear, he is much less optimistic about the ability of these drugs to revolutionize obesity medication in America. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Zach Reitano & Robert Lustig Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(401)

The New Book That Scares Big Tech

In the late 19th century, a railroad boom fueled by easy money, speculative investment, and new technology helped kick off one of the worst financial crises in American history. Sound kind of familiar...

8 Sep 59min

AI Slop Is Breaking the Internet. Can We Save It?

So many people seem to hate AI, and it’s not just because it might displace millions of jobs, destroy the world, or deepen distrust in big corporations and government. The reason might actually be sim...

1 Sep 56min

Why Everything Is Going to Keep Getting More Expensive

For much of the 21st century, the U.S. economy was built around cheap money. Today, though, interest rates are rising, and borrowing is getting much more expensive. At the same time, the federal gover...

25 Aug 41min

Higher Education’s Age of ‘Insufferable Hypocrisy’

It would be an understatement to say that higher education is in crisis, as it faces attacks from both the current presidential administration as well as issues of its own making, like diversity polit...

18 Aug 1h 2min

It May Be Time to Freak Out About AI

Today, Derek talks with cybersecurity expert Alex Stamos about a recent wave of alarming AI cyberattacks. For decades, one of the biggest fears about AI has been that the machines will start doing thi...

14 Aug 1h 17min

Why Americans Hate Data Centers

It seems a universal fact that AI has become an indispensable part of the American economy. At the same time, opposing AI has also become one of the most influential causes in American politics. Nowhe...

11 Aug 1h 3min

Why America Is Switching From Booze to Weed

Two extraordinary trends are happening in the United States simultaneously. One is that alcohol consumption is declining precipitously. The share of Americans who drink has hit a record low since Gall...

5 Aug 1h 9min

"The End of Reading Is Here"

There’s no doubt that reading is in decline. But what is that decline doing to the way we think? Derek talks with The Atlantic's Rose Horowitch about why Americans are reading fewer books than ever an...

28 Juli 53min